Your browser doesn't support javascript.
loading
Infectious complications of CAR T-cell therapy across novel antigen targets in the first 30 days.
Mikkilineni, Lekha; Yates, Bonnie; Steinberg, Seth M; Shahani, Shilpa A; Molina, John C; Palmore, Tara; Lee, Daniel W; Kaplan, Rosandra N; Mackall, Crystal L; Fry, Terry J; Gea-Banacloche, Juan; Jerussi, Theresa; Nussenblatt, Veronique; Kochenderfer, James N; Shah, Nirali N.
Afiliação
  • Mikkilineni L; Surgery Branch, National Cancer Institute.
  • Yates B; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute.
  • Steinberg SM; Biostatistics and Data Management Section, Office of the Clinical Director, Center for Cancer Research, National Cancer Institute, and.
  • Shahani SA; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute.
  • Molina JC; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute.
  • Palmore T; Laboratory of Clinical Immunology and Microbiology Infectious Disease, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
  • Lee DW; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute.
  • Kaplan RN; Division of Pediatric Hematology/Oncology, Department of Pediatrics, University of Virginia, Charlottesville, VA.
  • Mackall CL; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute.
  • Fry TJ; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute.
  • Gea-Banacloche J; Department of Pediatrics, Stanford University, Stanford, CA.
  • Jerussi T; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute.
  • Nussenblatt V; University of Colorado Anschutz Medical Campus and Center for Cancer and Blood Disorders, Children's Hospital of Colorado, Aurora, CO.
  • Kochenderfer JN; Division of Clinical Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD; and.
  • Shah NN; National Institutes of Health Clinical Center, Bethesda, MD.
Blood Adv ; 5(23): 5312-5322, 2021 12 14.
Article em En | MEDLINE | ID: mdl-34619768
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Mieloma Múltiplo Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Mieloma Múltiplo Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article